Ana sayfa
Piyasalar
Grafikler ve fikirler
Algo
Haberler
Store
Aracı kurumlar
İndir
Ekonomik Takvim
Alım-satım sinyalleri
Web Terminali
Arama yapmak için
/
tuşuna basın: @kullanıcı, $sembol, ...
Ara
Giriş yap
Hesap oluştur
Türkçe
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
HOLX
#555
Hologic Inc
75.360
0
+0.07%
Sektör:
Baz:
Kar para birimi:
Günlük aralık
Yıllık aralık
Günlük değişim
+0.07%
Aylık değişim
+0.23%
6 aylık değişim
+1.77%
Yıllık değişim
+1.77%
Önceki kapanış
75.305
0
Open
75.330
0
Bid
Ask
Low
75.310
0
High
75.360
0
Hacim
202
Piyasalar
ABD hisse senetleri
Sağlık hizmetleri
HOLX
Open full chart
Financials
Overview
Rapor
Statistics
Dividends
Quarterly
Annual
Income statement
Balance sheet
Cash flow
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Total assets
8.89 B
9.16 B
8.73 B
8.55 B
8.81 B
9.01 B
9.18 B
Total liabilities
3.94 B
4.03 B
3.96 B
3.93 B
3.96 B
3.97 B
3.94 B
Total equity
4.95 B
5.13 B
4.77 B
4.62 B
4.84 B
5.05 B
5.25 B
Total liabilities & shareholders' equities
8.89 B
9.16 B
8.73 B
8.55 B
8.81 B
9.01 B
9.18 B
Total debt
—
—
—
—
—
—
—
Net debt
—
—
—
—
—
—
—
Hologic Inc
Hologic, Inc. is an American medical technology company primarily focused on women's health; it sells medical devices for diagnostics, surgery, and medical imaging.
Haberler
HOLX vs. GEHC: Which Women's Health Stock Should You Pick Now?
Hologic hissesi 75,37 dolarda 52 haftalık zirve yaptı
Hologic stock hits 52-week high at 75.37 USD
How to Play Hologic Stock Post Q1 Earnings and Progress on Buyout?
Is Most-Watched Stock Hologic, Inc. (HOLX) Worth Betting on Now?
Soft Start For $10B-Plus M&A Deals In 2026
Hologic, Inc. (HOLX) Shareholder/Analyst Call - Slideshow (NASDAQ:HOLX) 2026-02-06
Hologic’s Aptima HPV assay receives FDA approval for primary screening
Hologic (HOLX) International Revenue Performance Explored
Hologic, Inc. (HOLX) is Attracting Investor Attention: Here is What You Should Know
HOLX Stock Slips on Q1 Earnings and Revenue Miss, Margins Crash
Compared to Estimates, Hologic (HOLX) Q1 Earnings: A Look at Key Metrics